One-dose drug reduced genetic bad cholesterol by 94% for almost a year
Researchers have conducted the first human trials of a new drug, lepodisiran, and found that a single injection reduced lipoprotein(a) – a ‘bad’ cholesterol with a genetic basis – to undetectable levels for almost a year. It has the potential to elimin… Continue reading One-dose drug reduced genetic bad cholesterol by 94% for almost a year
